價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2025-01-24 |
中文名稱:可伐利單抗 | 英文名稱:Research Grade Crovalimab (DHB90005) |
CAS:1917321-26-6 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Research Grade Crovalimab (DHB90005) | 靶點: CPAMD4, C5 |
宿主: Chimeric/Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Crovalimab (DHB90005) |
Catalog No.
DHB90005
Host species
Chimeric/Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
CPAMD4, C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P01031
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
RG-6107, RO7112689, SKY-59, CAS: 1917321-26-6
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 700萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥16000 |
VIP5年
|
武漢維斯爾曼生物工程有限公司
|
2025-01-20 | |
¥745 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-01-23 | |
¥3850 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2025-01-22 |